Cox Troy — SEC Form 4 filings
SEC reporting owner CIK 1696923. 12 Form 4 filings on record with FilingPulse; latest filed 2026-07-28.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-01-09 to 2026-07-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 15,620 shares, $148,702 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 28.
- Largest priced transaction: purchase of 15,620 shares @ $9.52 ($148,702) in MapLight Therapeutics, Inc., filed 2026-07-28.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| MapLight Therapeutics, Inc. (MPLT) | Director | 2 | 1 leg · 15,620 sh · $148,702 | — | 2 |
| STANDARD BIOTOOLS INC. (LAB) | Director | 7 | — | — | 16 |
| SomaLogic, Inc. (SLGC) | Director | 1 | — | — | 7 |
| SOPHiA GENETICS SA (SOPH) | Director | 1 | — | — | 2 |
| Zymeworks Inc. (ZYME) | Director | 1 | — | — | 1 |
Form 4 filings — Cox Troy
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-28 | 4 | MapLight Therapeutics, Inc. (MPLT) | Purchase (P): 15,620 @ $9.52 | EDGAR |
| 2026-06-25 | 4 | MapLight Therapeutics, Inc. (MPLT) | Grant/award (A): 7,864 @ $0 · Grant/award (A): 29,804 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4 | STANDARD BIOTOOLS INC. (LAB) | Grant/award (A): 99,116 @ $0 · Grant/award (A): 175,923 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | SOPHiA GENETICS SA (SOPH) | Grant/award (A): 19,724 @ $5.46 · Grant/award (A): 28,818 (derivative) @ $5.46 | EDGAR |
| 2026-03-02 | 4 | STANDARD BIOTOOLS INC. (LAB) | Grant/award (A): 57,264 @ $1.17 | EDGAR |
| 2025-07-30 | 4/A | STANDARD BIOTOOLS INC. (LAB) | Holdings only — no transactions reported | EDGAR |
| 2025-06-24 | 4 | STANDARD BIOTOOLS INC. (LAB) | Grant/award (A): 94,592 @ $0 · Grant/award (A): 125,660 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | STANDARD BIOTOOLS INC. (LAB) | Grant/award (A): 62,910 @ $1.06 | EDGAR |
| 2024-12-12 | 4 | Zymeworks Inc. (ZYME) | Grant/award (A): 31,000 (derivative) @ $0 | EDGAR |
| 2024-07-02 | 4 | STANDARD BIOTOOLS INC. (LAB) | Grant/award (A): 43,128 @ $0 · Grant/award (A): 72,213 (derivative) @ $0 | EDGAR |
| 2024-01-09 | 4 | STANDARD BIOTOOLS INC. (LAB) | Grant/award (A): 87,057 · Grant/award (A): 79,412 @ $0 · Grant/award (A): 31,635 · Grant/award (A): 51,842 (derivative) · Grant/award (A): 22,866 (derivative) · Grant/award (A): 982,811 (derivative) · +2 more | EDGAR |
| 2024-01-09 | 4 | SomaLogic, Inc. (SLGC) | Disposition to issuer (D): 78,430 · Disposition to issuer (D): 46,705 (derivative) · Disposition to issuer (D): 20,600 (derivative) · Disposition to issuer (D): 885,416 (derivative) · Disposition to issuer (D): 171,500 (derivative) · Disposition to issuer (D): 166,666 (derivative) · +1 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1696923 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →